RxDoctor Payments Data

Randolph Betts, MD

Family Medicine · Covina, CANPI 1932113685

Payments from drug & device makers

$976in general payments, 2019–2025

Across 50 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$191
  • Boehringer Ingelheim$82
  • Sanofi-aventis U.S. LLC$74
  • Novo Nordisk$73
  • Lilly USA, LLC$65
  • GSK$61
  • plus $430 from 14 others

What the payments were for

  • Food & beverage$976100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$976 in reported general payments places this provider in the 70th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$41,760
Medicare patients
108
Services billed
617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate63$49,942
JanumetSitagliptin Phos/Metformin Hcl42$24,994
EliquisApixaban61$24,758
MyrbetriqMirabegron25$12,072
FarxigaDapagliflozin Propanediol18$9,827
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,584
LinzessLinaclotide11$9,042
RestasisCyclosporine12$7,288
Breo ElliptaFluticasone/Vilanterol16$5,951
Spiriva HandihalerTiotropium Bromide12$5,782
Diclofenac Sodium211$5,226
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$3,404
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen150$3,161
Bethanechol Chloride24$3,150
Celecoxib51$2,878

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$55$74,936105 claims
PfizerEliquis$17$24,75861 claims
AbbVieLinzess, Restasis$35$16,33023 claims
GSKTrelegy Ellipta, Breo Ellipta$61$15,53531 claims
AstraZenecaFarxiga$23$9,82718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,533 family medicine providers in California.

Other family medicine in Covina

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →